Effector pathways of allergic reactions and their possible therapeutic modifications.
D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D001980:Bronchi / Q000276:immunology; D003165:Complement System Proteins; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D006968:Hypersensitivity, Delayed; D007073:Immunoglobulin E; D007136:Immunoglobulins; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
D005938:Glucocorticoids; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D014688:Venoms; D007073:Immunoglobulin E; D006493:Heparin; D003165:Complement System Proteins; D004205:Cromolyn Sodium